文献速递前列腺癌

根治性前列腺切除术后预期寿命延长与非前列腺癌死亡关系量化

Quantifying the Relationship Between Increasing Life Expectancy and Nonprostate Cancer Mortality After Radical Prostatectomy.
PubMed 文献 · Urology · 2020-04-22

单中心6809例根治性前列腺切除术患者(1992–2016年,中位年龄65岁,中位随访7.9年)的竞争风险分析显示,控制年龄后非前列腺癌死亡率显著下降,24年间累积效应相当于6.3个日历年龄年;65岁及以上患者获益8.1年,而65岁以下仅1年。

要点

  • 根治性前列腺切除术后非前列腺癌死亡率随手术年份显著下降
  • 24年死亡率下降等效于6.3个日历年龄年
  • 65岁及以上患者非前列腺癌死亡率下降最明显(8.1年获益)

核心结论

  • 控制年龄后,根治性前列腺切除术后非前列腺癌死亡率在观察期内显著下降,累积效应相当于6.3个日历年龄年。

研究设计与样本

  • 单中心连续6809例根治性前列腺切除术患者,手术年份1992–2016年,中位年龄65岁,中位随访7.9年,采用多变量竞争风险分析。

主要发现

  • 非前列腺癌死亡率下降主要见于65岁及以上患者,相当于8.1年获益;65岁以下患者仅约1年获益。
  • 手术时平均年龄轻度增加2.7年,但远不能抵消非前列腺癌死亡风险的下降。

关键数值与推荐

  • 24年累积的非前列腺癌死亡率下降对应6.3个日历年龄年的效应。
  • 65岁及以上患者非前列腺癌死亡率下降对应8.1年获益;65岁以下患者仅1年获益。
  • 手术时平均年龄增加2.7年。

临床怎么用

  • 临床医生应认识到老年根治性前列腺切除术候选者的竞争死亡风险正在下降,以避免治疗不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the relationship between increasing life expectancy and nonprostate cancer (competing) mortality after radical prostatectomy. PATIENTS AND METHODS: We studied a single-center sample of 6809 consecutive patients who underwent radical prostatectomy between 1992 and 2016 with a median age of 65 years and a median follow-up of 7.9 years. Multivariate competing risk analyses were performed with competing mortality as endpoint. Linear trends over the years of surgery for 5-year competing mortality rates and for mean ages were calculated using linear regression analyses. We estimated the number of live years gained over time using a heuristic model-based calculation: (hazard ratio year of surgery) 24 calendar years × (hazard ratio age at surgery) gained life years = 1. RESULTS: After controlling for age, nonprostate cancer mortality decreased significantly during the observation period. Accumulated over the 24 years, this decrease of mortality corresponded to the effect of 6.3 years of calendric age. Most of the decrease in nonprostate cancer mortality (predominantly attributable to noncancer causes of death) was seen in patients aged 65 years or older (8.1 years gained), whereas there was only a marginal decrease in patients younger than 65 years (only 1 year gained). The decrease in nonprostate cancer mortality was accompanied by a slight increase of mean age at surgery (2.7 years) that did not nearly compensate the decreasing risk. CONCLUSION: Clinicians should be aware of the decreasing competing mortality risk in elderly candidates for radical prostatectomy in order to avoid undertreatment.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Froehner M, Koch R, Hübler M, et al. Quantifying the Relationship Between Increasing Life Expectancy and Nonprostate Cancer Mortality After Radical Prostatectomy. Urology. 2020. PMID: 32333981. doi:10.1016/j.urology.2020.04.053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。